bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.920
-0.070 (-3.52%)
May 15, 2026, 3:29 PM EDT - Market open
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
57
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$99,296
Profits / Employee
-$278,596
Market Cap
8.63M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57 | 0 | - |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inotiv | 2,046 |
| FONAR | 535 |
| MDxHealth | 364 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| Advanced Biomed | 31 |
| ENDRA Life Sciences | 21 |
BIAF News
- 3 days ago - BioAffinity says CyPath Lung test unit sales achieved monthly record in April - TheFly
- 3 days ago - bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 - Business Wire
- 7 days ago - BioAffinity Technologies reports Q1 EPS (81c) vs. ($4.80) last year - TheFly
- 7 days ago - bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung - Business Wire
- 14 days ago - BioAffinity Technologies files to sell 497,483 shares of common stock for holder - TheFly
- 17 days ago - BioAffinity Technologies launches new study to expand use of CyPath lung tech - TheFly
- 17 days ago - bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment - Business Wire
- 4 weeks ago - BioAffinity Technologies releases clinical case on CyPath Lung - TheFly